Labcorp Holdings Inc. (LH) is a publicly traded Healthcare sector company. As of August 24, 2026, LH trades at $336.34 with a market cap of $27.28B and a P/E ratio of 27.64. LH moved +1.06% today. Year to date, LH is +34.06%; over the trailing twelve months it is +21.62%. Its 52-week range spans $209.38 to $338.19. Analyst consensus is strong buy with an average price target of $338.27. Rallies surfaces LH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $336.34 |
| Market Cap | $27.28B |
| P/E Ratio | 27.64 |
| EPS | $12.17 |
| Dividend Yield | 0.72% |
| 52-Week High | $338.19 |
| 52-Week Low | $209.38 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $14.35B |
| Net Income | $1.00B |
| Gross Margin | 28.88% |
12 analysts cover LH: 0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $338.27.